{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:00:10Z","timestamp":1793761210120,"version":"4.6.1"},"reference-count":267,"publisher":"Rockefeller University Press","issue":"4","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,3]]},"abstract":"<jats:p>Five years ago, we launched the COVID Human Genetic Effort. Our goal was to explain the clinical variability among SARS-CoV-2\u2013exposed individuals by searching for monogenic inborn errors of immunity and their phenocopies. We deciphered the pathogenesis of critical COVID-19 pneumonia and multisystem inflammatory syndrome in children in \u223c15% and 2% of cases, respectively, thereby revealing general mechanisms of severe disease. We also defined neuro-COVID genetically and immunologically in one child, while we delineated the immunological mechanisms of COVID-toes in healthy children and young adults, paving the way for their genetic study. Understanding the human genetic and immunological basis of resistance to SARS-CoV-2 infection, long COVID, and myocarditis after mRNA vaccination has been challenging, and investigations remain ongoing. This work highlights the power of patient-based basic research and large-scale international collaborative efforts to discover human genetic and immunological drivers of infectious disease phenotypes, with implications for the timely development of new medical strategies before the next pandemic arrives.<\/jats:p>","DOI":"10.70962\/jhi.20250149","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T06:21:34Z","timestamp":1758694894000},"update-policy":"https:\/\/doi.org\/10.70962\/jhi.crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["The seven enigmas of SARS-CoV-2: From the past to the future"],"prefix":"10.70962","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5536-1661","authenticated-orcid":true,"given":"Evangelos","family":"Andreakos","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00gban551","id-type":"ROR","asserted-by":"publisher"}],"name":"Center for Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens 1 Laboratory of Immunobiology, , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0468-9568","authenticated-orcid":true,"given":"Lisa","family":"Arkin","sequence":"additional","affiliation":[{"name":"University of Wisconsin School of Medicine and Public Health 2 Department of Dermatology, , Madison, WI,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5926-8437","authenticated-orcid":true,"given":"Paul","family":"Bastard","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02vjkv261","id-type":"ROR","asserted-by":"publisher"}],"name":"Necker Branch, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1163, Necker Hospital for Sick Children 3 Laboratory of Human Genetics of Infectious Diseases, , Paris,","place":["France"]},{"name":"Imagine Institute, Paris Cit\u00e9 University 4 , Paris,","place":["France"]},{"id":[{"id":"https:\/\/ror.org\/0420db125","id-type":"ROR","asserted-by":"publisher"}],"name":"Rockefeller University 5 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, , New York, NY,","place":["USA"]},{"name":"Necker Hospital for Sick Children, Assistance Publique-H\u00f4pitaux de Paris 6 Pediatric Hematology-Immunology and Rheumatology Unit, , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7399-2766","authenticated-orcid":true,"given":"Alexandre","family":"Bolze","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056jgxp12","id-type":"ROR","asserted-by":"publisher"}],"name":"Helix 7 , San Mateo, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8773-9144","authenticated-orcid":true,"given":"Alessandro","family":"Borghesi","sequence":"additional","affiliation":[{"name":"8Host-Pathogen Group and Neonatal Intensive Care Unit, 'IRCCS' San Matteo Research Hospital, Pavia, Italy"},{"name":"Neonatal Intensive Care Unit, Mother, Child and Adolescent Department, Geneva University Hospitals 29 , Geneva,","place":["Switzerland"]},{"name":"Department of Pediatrics, Gynecology and Obstetrics, University of Geneva 30 , Geneva,","place":["Switzerland"]},{"name":"School of Life Sciences, Swiss Federal Institute of Technology 31 , Lausanne,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8103-0046","authenticated-orcid":true,"given":"Petter","family":"Brodin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/056d84691","id-type":"ROR","asserted-by":"publisher"}],"name":"Karolinska Institutet 9 Department of Women\u2019s and Children\u2019s Health, , Stockholm,","place":["Sweden"]},{"id":[{"id":"https:\/\/ror.org\/041kmwe10","id-type":"ROR","asserted-by":"publisher"}],"name":"Imperial College London 10 Stockholm Department of Immunology and Inflammation, , London,","place":["UK"]},{"name":"Imperial College Hammersmith Campus 11 Medical Research Council Laboratory of Medical Sciences, , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7782-4169","authenticated-orcid":true,"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02vjkv261","id-type":"ROR","asserted-by":"publisher"}],"name":"Necker Branch, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1163, Necker Hospital for Sick Children 3 Laboratory of Human Genetics of Infectious Diseases, , Paris,","place":["France"]},{"name":"Imagine Institute, Paris Cit\u00e9 University 4 , Paris,","place":["France"]},{"id":[{"id":"https:\/\/ror.org\/0420db125","id-type":"ROR","asserted-by":"publisher"}],"name":"Rockefeller University 5 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, , New York, NY,","place":["USA"]},{"name":"Howard Hughes Medical Institute 12 , New York, NY,","place":["USA"]},{"name":"Necker Hospital for Sick Children 13 Department of Pediatrics, , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0115-8980","authenticated-orcid":true,"given":"Giorgio","family":"Casari","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01gmqr298","id-type":"ROR","asserted-by":"publisher"}],"name":"Vita-Salute San Raffaele University 14 , Milan,","place":["Italy"]},{"name":"IRCCS San Raffaele Scientific Institute 15 , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7209-6257","authenticated-orcid":true,"given":"Aur\u00e9lie","family":"Cobat","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02vjkv261","id-type":"ROR","asserted-by":"publisher"}],"name":"Necker Branch, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1163, Necker Hospital for Sick Children 3 Laboratory of Human Genetics of Infectious Diseases, , Paris,","place":["France"]},{"name":"Imagine Institute, Paris Cit\u00e9 University 4 , Paris,","place":["France"]},{"id":[{"id":"https:\/\/ror.org\/0420db125","id-type":"ROR","asserted-by":"publisher"}],"name":"Rockefeller University 5 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, , New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0844-7195","authenticated-orcid":true,"given":"Beth","family":"Drolet","sequence":"additional","affiliation":[{"name":"University of Wisconsin School of Medicine and Public Health 2 Department of Dermatology, , Madison, WI,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8240-939X","authenticated-orcid":true,"given":"Jacques","family":"Fellay","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02s376052","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Life Sciences, \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne 16 , Lausanne,","place":["Switzerland"]},{"name":"Biomedical Data Science Center, Lausanne University Hospital and University of Lausanne 17 , Lausanne,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3969-6597","authenticated-orcid":true,"given":"Elena W.Y.","family":"Hsieh","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine 18 Department of Pediatrics, Section of Allergy and Immunology, Department of Immunology and Microbiology, , Aurora, CO,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-0302","authenticated-orcid":true,"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Transplantation, KU Leuven 19 Laboratory for Inborn Errors of Immunity, , Leuven,","place":["Belgium"]},{"name":"University Hospitals Leuven 20 Department of Pediatrics, , Leuven,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1853-9704","authenticated-orcid":true,"given":"Trine H.","family":"Mogensen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01aj84f44","id-type":"ROR","asserted-by":"publisher"}],"name":"Aarhus University 21 Department of Biomedicine, , Aarhus,","place":["Denmark"]},{"name":"Aarhus University Hospital 22 Department of Infectious Diseases, , Aarhus,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3519-0727","authenticated-orcid":true,"given":"Vanessa","family":"Sancho-Shimizu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/041kmwe10","id-type":"ROR","asserted-by":"publisher"}],"name":"Imperial College London 23 Department of Infectious Disease, Faculty of Medicine, , London,","place":["UK"]},{"id":[{"id":"https:\/\/ror.org\/041kmwe10","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre for Paediatrics and Child Health, Faculty of Medicine, Imperial College London 24 , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5981-7259","authenticated-orcid":true,"given":"Andr\u00e1s N.","family":"Spaan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0575yy874","id-type":"ROR","asserted-by":"publisher"}],"name":"University Medical Center Utrecht, Utrecht University 25 Department of Medical Microbiology, , Utrecht,","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5582-9110","authenticated-orcid":true,"given":"Helen C.","family":"Su","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"publisher"}],"name":"Intramural Research Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health 26 Human Immunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, , Bethesda, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1347-7767","authenticated-orcid":true,"given":"Donald C.","family":"Vinh","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04cpxjv19","id-type":"ROR","asserted-by":"publisher"}],"name":"McGill University Health Centre 27 Department of Medicine, Division of Infectious Diseases, , Montr\u00e9al,","place":["Canada"]},{"id":[{"id":"https:\/\/ror.org\/04cpxjv19","id-type":"ROR","asserted-by":"publisher"}],"name":"Centre of Reference for Genetic Research in Infection and Immunity, Research Institute-McGill University Health Centre 28 , Montr\u00e9al,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4859-4085","authenticated-orcid":true,"given":"Ahmad","family":"Yatim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02vjkv261","id-type":"ROR","asserted-by":"publisher"}],"name":"Necker Branch, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1163, Necker Hospital for Sick Children 3 Laboratory of Human Genetics of Infectious Diseases, , Paris,","place":["France"]},{"name":"Imagine Institute, Paris Cit\u00e9 University 4 , Paris,","place":["France"]},{"id":[{"id":"https:\/\/ror.org\/0420db125","id-type":"ROR","asserted-by":"publisher"}],"name":"Rockefeller University 5 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, , New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9040-3289","authenticated-orcid":true,"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02vjkv261","id-type":"ROR","asserted-by":"publisher"}],"name":"Necker Branch, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1163, Necker Hospital for Sick Children 3 Laboratory of Human Genetics of Infectious Diseases, , Paris,","place":["France"]},{"name":"Imagine Institute, Paris Cit\u00e9 University 4 , Paris,","place":["France"]},{"id":[{"id":"https:\/\/ror.org\/0420db125","id-type":"ROR","asserted-by":"publisher"}],"name":"Rockefeller University 5 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, , New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9449-3672","authenticated-orcid":true,"given":"Shen-Ying","family":"Zhang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02vjkv261","id-type":"ROR","asserted-by":"publisher"}],"name":"Necker Branch, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1163, Necker Hospital for Sick Children 3 Laboratory of Human Genetics of Infectious Diseases, , Paris,","place":["France"]},{"name":"Imagine Institute, Paris Cit\u00e9 University 4 , Paris,","place":["France"]},{"id":[{"id":"https:\/\/ror.org\/0420db125","id-type":"ROR","asserted-by":"publisher"}],"name":"Rockefeller University 5 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, , New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"COVID Human Genetic Effort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Al-Muhsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Andreakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s A.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Arkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit Baris","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bastard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bolze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiia","family":"Bondarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Borghesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Bousfiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Casari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Cobat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Colobran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Condino-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan N.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Drolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munis","family":"D\u00fcndar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Espinosa-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Fellay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Froidure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Gorochov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabih","family":"Halwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena W.Y.","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Itan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Jouanguy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Kaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lung","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Mar\u00f3di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine H.","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa F.P.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firat","family":"Ozcelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Pan-Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Perez de Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Perlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Puel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Renia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Sancho-Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shahrooei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shcherbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Slaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Soler-Palac\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s N.","family":"Spaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Tancevski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart G.","family":"Tangye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Abou","family":"Tayoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thorball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tiberghien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart E.","family":"Turvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"Vinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"2025102410025648400_bib1","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2020.05.016","article-title":"A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection","volume":"181","author":"Casanova","year":"2020","journal-title":"Cell"},{"key":"2025102410025648400_bib2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev-biodatasci-020222-021705","article-title":"Human genomics of COVID-19 pneumonia: Contributions of rare and common variants","volume":"6","author":"Cobat","year":"2023","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"2025102410025648400_bib3","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250001","article-title":"Human immunity","volume":"1","author":"Casanova","year":"2025","journal-title":"J. Hum. Immun."},{"key":"2025102410025648400_bib4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-micro-092123-022855","article-title":"The microbe, the infection enigma, and the host","volume":"78","author":"Casanova","year":"2024","journal-title":"Annu. Rev. Microbiol."},{"key":"2025102410025648400_bib5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.medj.2020.12.001","article-title":"Life-threatening COVID-19: Defective interferons unleash excessive inflammation","volume":"1","author":"Zhang","year":"2020","journal-title":"Med"},{"key":"2025102410025648400_bib6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41586-022-04447-0","article-title":"Human genetic and immunological determinants of critical COVID-19 pneumonia","volume":"603","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"2025102410025648400_bib7","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"2025102410025648400_bib8","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67569","article-title":"Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study","volume":"10","author":"Fallerini","year":"2021","journal-title":"Elife"},{"key":"2025102410025648400_bib9","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in \u223c1% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci. Immunol."},{"key":"2025102410025648400_bib10","doi-asserted-by":"publisher","first-page":"719115","DOI":"10.3389\/fimmu.2021.719115","article-title":"Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19","volume":"12","author":"Solanich","year":"2021","journal-title":"Front. Immunol."},{"key":"2025102410025648400_bib11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-021-01151-y","article-title":"X-linked TLR7 deficiency underlies critical COVID-19 pneumonia in a male patient with ataxia-telangiectasia","volume":"42","author":"Abolhassani","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib268","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"key":"2025102410025648400_bib12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220131","article-title":"Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia","volume":"219","author":"Zhang","year":"2022","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220170","article-title":"Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia","volume":"220","author":"Garc\u00eda-Garc\u00eda","year":"2023","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI168321","article-title":"Human inherited complete STAT2 deficiency underlies inflammatory viral diseases","volume":"133","author":"Bucciol","year":"2023","journal-title":"J. Clin. Invest."},{"key":"2025102410025648400_bib15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41525-021-00220-w","article-title":"TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19","volume":"6","author":"Schmidt","year":"2021","journal-title":"NPJ Genom. Med."},{"key":"2025102410025648400_bib16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13073-023-01173-8","article-title":"Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19","volume":"15","author":"Matuozzo","year":"2023","journal-title":"Genome Med."},{"key":"2025102410025648400_bib17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20212427","article-title":"Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic","volume":"219","author":"Duncan","year":"2022","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220028","article-title":"A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes","volume":"219","author":"Bastard","year":"2022","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20241413","article-title":"A common form of dominant human IFNAR1 deficiency impairs IFN-alpha and -omega but not IFN-beta-dependent immunity","volume":"222","author":"Al Qureshah","year":"2025","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib20","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"2025102410025648400_bib21","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci. Immunol."},{"key":"2025102410025648400_bib22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200413119","article-title":"The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies","volume":"119","author":"Manry","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025102410025648400_bib23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231353","article-title":"Higher COVID-19 pneumonia risk associated with anti-IFN-\u03b1 than with anti-IFN-\u03c9 auto-Abs in children","volume":"221","author":"Bastard","year":"2024","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220491","article-title":"Null IFNAR1 and IFNAR2 alleles are surprisingly common in the Pacific and Arctic","volume":"219","author":"Meyts","year":"2022","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib25","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1038\/s41586-023-06355-3","article-title":"A second update on mapping the human genetic architecture of COVID-19","volume":"621","author":"COVID-19 Host Genetics Initiative","year":"2023","journal-title":"Nature"},{"key":"2025102410025648400_bib26","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/s41586-022-04826-7","article-title":"A first update on mapping the human genetic architecture of COVID-19","volume":"608","author":"COVID-19 Host Genetics Initiative","year":"2022","journal-title":"Nature"},{"key":"2025102410025648400_bib27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","article-title":"Mapping the human genetic architecture of COVID-19","volume":"600","author":"COVID-19 Host Genetics Initiative","year":"2021","journal-title":"Nature"},{"key":"2025102410025648400_bib28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41586-022-05163-5","article-title":"DOCK2 is involved in the host genetics and biology of severe COVID-19","volume":"609","author":"Namkoong","year":"2022","journal-title":"Nature"},{"key":"2025102410025648400_bib29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2026309118","article-title":"A genomic region associated with protection against severe COVID-19 is inherited from Neandertals","volume":"118","author":"Zeberg","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025102410025648400_bib30","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1126\/science.1139522","article-title":"TLR3 deficiency in patients with herpes simplex encephalitis","volume":"317","author":"Zhang","year":"2007","journal-title":"Science"},{"key":"2025102410025648400_bib31","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1126\/science.1128346","article-title":"Herpes simplex virus encephalitis in human UNC-93B deficiency","volume":"314","author":"Casrouge","year":"2006","journal-title":"Science"},{"key":"2025102410025648400_bib32","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.20111316","article-title":"Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood","volume":"209","author":"Herman","year":"2012","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib33","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1084\/jem.20142274","article-title":"Functional IRF3 deficiency in a patient with herpes simplex encephalitis","volume":"212","author":"Andersen","year":"2015","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib34","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1172\/JCI59259","article-title":"Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency","volume":"121","author":"Sancho-Shimizu","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2025102410025648400_bib35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139980","article-title":"Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency","volume":"131","author":"Bastard","year":"2021","journal-title":"J. Clin. Invest."},{"key":"2025102410025648400_bib36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240637","article-title":"Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in approximately 10% of patients","volume":"221","author":"Gervais","year":"2024","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230661","article-title":"Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in \u223c40% of patients","volume":"220","author":"Gervais","year":"2023","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1126\/science.aaa1578","article-title":"Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency","volume":"348","author":"Ciancanelli","year":"2015","journal-title":"Science"},{"key":"2025102410025648400_bib39","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1084\/jem.20181621","article-title":"Severe influenza pneumonitis in children with inherited TLR3 deficiency","volume":"216","author":"Lim","year":"2019","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib40","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220514","article-title":"Autoantibodies against type I IFNs in patients with critical influenza pneumonia","volume":"219","author":"Zhang","year":"2022","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib41","doi-asserted-by":"publisher","first-page":"307ra154","DOI":"10.1126\/scitranslmed.aac4227","article-title":"Human IFNAR2 deficiency: Lessons for antiviral immunity","volume":"7","author":"Duncan","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"2025102410025648400_bib42","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1084\/jem.20182295","article-title":"Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines","volume":"216","author":"Hernandez","year":"2019","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib43","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib44","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13116","article-title":"Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trial","volume":"17","author":"Alotaibi","year":"2023","journal-title":"Influenza Other Respir. Viruses"},{"key":"2025102410025648400_bib45","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.15585\/mmwr.mm6940e1","article-title":"Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection - United Kingdom and United States, March-August 2020","volume":"69","author":"Morris","year":"2020","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"2025102410025648400_bib46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210446","article-title":"SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?","volume":"218","author":"Sancho-Shimizu","year":"2021","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical Characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2","volume":"324","author":"Whittaker","year":"2020","journal-title":"JAMA"},{"key":"2025102410025648400_bib48","doi-asserted-by":"publisher","first-page":"100527","DOI":"10.1016\/j.eclinm.2020.100527","article-title":"Multisystem inflammatory syndrome in children: A systematic review","volume":"26","author":"Ahmed","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2025102410025648400_bib49","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","article-title":"Multisystem inflammatory syndrome in children in New York state","volume":"383","author":"Dufort","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.16420","article-title":"Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2","volume":"4","author":"Payne","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"2025102410025648400_bib51","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19","volume":"325","author":"Feldstein","year":"2021","journal-title":"JAMA"},{"key":"2025102410025648400_bib52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/INF.0000000000004206","article-title":"COVID-19 vaccine acceptance among parents of children with multisystem inflammatory syndrome in children","volume":"43","author":"Blanchard-Rohner","year":"2024","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2025102410025648400_bib53","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ccm.2024.02.019","article-title":"COVID-19 in pediatric populations","volume":"45","author":"Okuducu","year":"2024","journal-title":"Clin. Chest Med."},{"key":"2025102410025648400_bib54","doi-asserted-by":"publisher","first-page":"100604","DOI":"10.1016\/j.lanwpc.2022.100604","article-title":"Lower risk of Multi-system inflammatory syndrome in children (MIS-C) with the omicron variant","volume":"27","author":"Lopez","year":"2022","journal-title":"Lancet Reg. Health West. Pac."},{"key":"2025102410025648400_bib55","doi-asserted-by":"publisher","first-page":"111105","DOI":"10.1016\/j.intimp.2023.111105","article-title":"The protective effects of pediatric vaccination on multisystem inflammatory syndrome in children stratified by vaccine status, types and virus variants","volume":"125","author":"Zhang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"2025102410025648400_bib56","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41591-020-1054-6","article-title":"Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection","volume":"26","author":"Carter","year":"2020","journal-title":"Nat. Med."},{"key":"2025102410025648400_bib57","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The immunology of multisystem inflammatory syndrome in children with COVID-19","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell"},{"key":"2025102410025648400_bib58","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00431-021-03993-5","article-title":"Multisystem inflammatory syndrome in children related to COVID-19: A systematic review","volume":"180","author":"Hoste","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"2025102410025648400_bib59","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10875-020-00941-0","article-title":"Distinctive features of Kawasaki disease following SARS-CoV-2 infection: A controlled study in Paris, France","volume":"41","author":"Toubiana","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib60","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1093\/rheumatology\/keab026","article-title":"Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: A French study and literature review","volume":"60","author":"Cherqaoui","year":"2021","journal-title":"Rheumatology"},{"key":"2025102410025648400_bib62","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41591-022-01724-3","article-title":"Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19","volume":"28","author":"Sacco","year":"2022","journal-title":"Nat. Med."},{"key":"2025102410025648400_bib63","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf7570","article-title":"Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19","volume":"6","author":"Vella","year":"2021","journal-title":"Sci. Immunol."},{"key":"2025102410025648400_bib64","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abh1516","article-title":"Polyclonal expansion of TCR Vbeta 21.3(+) CD4(+) and CD8(+) T cells is a hallmark of multisystem inflammatory syndrome in children","volume":"6","author":"Moreews","year":"2021","journal-title":"Sci. Immunol."},{"key":"2025102410025648400_bib65","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.medj.2021.08.002","article-title":"A monocyte\/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis","volume":"2","author":"de Cevins","year":"2021","journal-title":"Med"},{"key":"2025102410025648400_bib66","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.immuni.2021.04.003","article-title":"Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children","volume":"54","author":"Ramaswamy","year":"2021","journal-title":"Immunity"},{"key":"2025102410025648400_bib67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40124-021-00257-6","article-title":"Current insights into the pathophysiology of multisystem inflammatory syndrome in children","volume":"9","author":"Vella","year":"2021","journal-title":"Curr. Pediatr. Rep."},{"key":"2025102410025648400_bib68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146614","article-title":"HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children","volume":"131","author":"Porritt","year":"2021","journal-title":"J. Clin. Invest."},{"key":"2025102410025648400_bib69","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211381","article-title":"TIM3+ TRBV11-2 T cells and IFNgamma signature in patrolling monocytes and CD16+ NK cells delineate MIS-C","volume":"219","author":"Hoste","year":"2022","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib70","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1126\/science.abj7965","article-title":"Mechanisms of viral inflammation and disease in humans","volume":"374","author":"Casanova","year":"2021","journal-title":"Science"},{"key":"2025102410025648400_bib71","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo3627","article-title":"Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children","volume":"379","author":"Lee","year":"2023","journal-title":"Science"},{"key":"2025102410025648400_bib72","doi-asserted-by":"publisher","first-page":"12720","DOI":"10.1128\/JVI.01471-07","article-title":"Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response","volume":"81","author":"Silverman","year":"2007","journal-title":"J. Virol."},{"key":"2025102410025648400_bib73","doi-asserted-by":"publisher","first-page":"8035","DOI":"10.4049\/jimmunol.0902728","article-title":"Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection","volume":"183","author":"Lin","year":"2009","journal-title":"J. Immunol."},{"key":"2025102410025648400_bib74","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.febslet.2012.11.010","article-title":"The ribonuclease L-dependent antiviral roles of human 2',5'-oligoadenylate synthetase family members against hepatitis C virus","volume":"587","author":"Kwon","year":"2013","journal-title":"FEBS Lett."},{"key":"2025102410025648400_bib75","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1073\/pnas.1519657113","article-title":"Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025102410025648400_bib76","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240699","article-title":"Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)","volume":"221","author":"Bellos","year":"2024","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib77","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41586-025-08697-6","article-title":"TGF\u03b2 links EBV to multisystem inflammatory syndrome in children","volume":"640","author":"Goetzke","year":"2025","journal-title":"Nature"},{"key":"2025102410025648400_bib78","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073923","article-title":"Pathophysiology, diagnosis, and management of neuroinflammation in covid-19","volume":"382","author":"Brown","year":"2023","journal-title":"BMJ"},{"key":"2025102410025648400_bib79","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMc2019373","article-title":"Neuropathological features of covid-19","volume":"383","author":"Solomon","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib80","doi-asserted-by":"publisher","first-page":"e2035","DOI":"10.1212\/WNL.0000000000207900","article-title":"Association between guillain-barre syndrome and COVID-19 infection and vaccination: A population-based nested case-control study","volume":"101","author":"Bishara","year":"2023","journal-title":"Neurology"},{"key":"2025102410025648400_bib81","doi-asserted-by":"publisher","first-page":"102983","DOI":"10.1016\/j.autrev.2021.102983","article-title":"To be, or not to be\u2026 Guillain-Barr\u00e9 Syndrome","volume":"20","author":"Florian","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"2025102410025648400_bib82","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202135","article-title":"Neuroinvasion of SARS-CoV-2 in human and mouse brain","volume":"218","author":"Song","year":"2021","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib83","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jama.2020.14254","article-title":"Neurology and COVID-19","volume":"324","author":"Josephson","year":"2020","journal-title":"JAMA"},{"key":"2025102410025648400_bib84","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41422-020-0390-x","article-title":"SARS-CoV-2 infects human neural progenitor cells and brain organoids","volume":"30","author":"Zhang","year":"2020","journal-title":"Cell Res."},{"key":"2025102410025648400_bib85","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.coi.2021.07.004","article-title":"Neuron-intrinsic immunity to viruses in mice and humans","volume":"72","author":"Zhang","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"2025102410025648400_bib86","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231725","article-title":"SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency","volume":"221","author":"Chan","year":"2024","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib87","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.cell.2018.02.019","article-title":"Inborn errors of RNA lariat metabolism in humans with brainstem viral infection","volume":"172","author":"Zhang","year":"2018","journal-title":"Cell"},{"key":"2025102410025648400_bib88","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/bmj.1.1411.58","article-title":"Harveian lectures on lupus","volume":"1","author":"Hutchinson","year":"1888","journal-title":"Br. Med. J."},{"key":"2025102410025648400_bib89","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/521373","article-title":"Clinical and molecular phenotype of Aicardi-Goutieres syndrome","volume":"81","author":"Rice","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"2025102410025648400_bib90","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1136\/annrheumdis-2016-209841","article-title":"Familial chilblain lupus due to a gain-of-function mutation in STING","volume":"76","author":"K\u00f6nig","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"2025102410025648400_bib91","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"2025102410025648400_bib92","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jaad.2024.11.014","article-title":"A global retrospective study identifies higher rates of pernio in individuals with connective tissue disease","volume":"92","author":"Arora","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"key":"2025102410025648400_bib93","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232066","article-title":"Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus","volume":"221","author":"David","year":"2024","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib94","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1001\/jamadermatol.2021.2120","article-title":"Epidemiologic analysis of chilblains cohorts before and during the COVID-19 pandemic","volume":"157","author":"McCleskey","year":"2021","journal-title":"JAMA Dermatol."},{"key":"2025102410025648400_bib95","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/jpc.12094","article-title":"Major cluster of chilblain cases in a cold dry Western Australian winter","volume":"49","author":"Larkins","year":"2013","journal-title":"J. Paediatr. Child Health"},{"key":"2025102410025648400_bib96","first-page":"185","article-title":"A cluster of chilblains in Hong Kong","volume":"14","author":"Chan","year":"2008","journal-title":"Hong Kong Med. J."},{"key":"2025102410025648400_bib97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000488","article-title":"Snotwatch COVID-toes: An ecological study of chilblains and COVID-19 diagnoses in Victoria, Australia","volume":"2","author":"Sawires","year":"2022","journal-title":"PLOS Glob. Public Health"},{"key":"2025102410025648400_bib98","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-virology-012420-022445","article-title":"Seasonality of respiratory viral infections","volume":"7","author":"Moriyama","year":"2020","journal-title":"Annu. Rev. Virol."},{"key":"2025102410025648400_bib99","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jaad.2020.05.109","article-title":"Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"2025102410025648400_bib100","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/pde.14227","article-title":"Clustered cases of acral perniosis: Clinical features, histopathology, and relationship to COVID-19","volume":"37","author":"Cordoro","year":"2020","journal-title":"Pediatr. Dermatol."},{"key":"2025102410025648400_bib101","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jaad.2020.06.019","article-title":"Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic","volume":"83","author":"Colonna","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"2025102410025648400_bib102","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/pde.14566","article-title":"Acral Changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research alliance (PeDRA)","volume":"38","author":"Castelo-Soccio","year":"2021","journal-title":"Pediatr. Dermatol."},{"key":"2025102410025648400_bib103","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jaad.2020.09.086","article-title":"Chilblain-like lesions and COVID-19 infection: A prospective observational study at Spain's ground zero","volume":"84","author":"Feito-Rodr\u00edguez","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"2025102410025648400_bib104","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1111\/jdv.17393","article-title":"Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic","volume":"35","author":"Moghadam","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2025102410025648400_bib105","doi-asserted-by":"publisher","first-page":"e556","DOI":"10.1111\/jdv.17378","article-title":"Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology","volume":"35","author":"Giraud-Kerleroux","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2025102410025648400_bib106","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/pde.14948","article-title":"Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic","volume":"39","author":"Bascuas-Arribas","year":"2022","journal-title":"Pediatr. Dermatol."},{"key":"2025102410025648400_bib107","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/bjd.21693","article-title":"Pernio and early SARS-CoV-2 variants: Natural history of a prospective cohort and the role of interferon","volume":"187","author":"Ng","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"2025102410025648400_bib108","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bjd.19349","article-title":"No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain","volume":"183","author":"Caselli","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"2025102410025648400_bib109","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2122090119","article-title":"Lack of association between pandemic chilblains and SARS-CoV-2 infection","volume":"119","author":"Gehlhausen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025102410025648400_bib110","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/bjd.19377","article-title":"Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing","volume":"183","author":"Le Cleach","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"2025102410025648400_bib111","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/bjd.20647","article-title":"Analysis of T-cell responses directed against the spike and\/or membrane and\/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemic","volume":"185","author":"Cassius","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"2025102410025648400_bib112","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/jdv.17672","article-title":"Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis","volume":"36","author":"S\u00e1nchez-Garc\u00eda","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2025102410025648400_bib113","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/jamadermatol.2020.2368","article-title":"Evaluation of chilblains as a manifestation of the COVID-19 pandemic","volume":"156","author":"Herman","year":"2020","journal-title":"JAMA Dermatol."},{"key":"2025102410025648400_bib114","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1111\/jdv.16751","article-title":"Major cluster of paediatric \u201ctrue\u201d primary chilblains during the COVID-19 pandemic: A consequence of lifestyle changes due to lockdown","volume":"34","author":"Neri","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"2025102410025648400_bib115","doi-asserted-by":"publisher","first-page":"109959","DOI":"10.1016\/j.mehy.2020.109959","article-title":"A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?","volume":"144","author":"Lipsker","year":"2020","journal-title":"Med. Hypotheses"},{"key":"2025102410025648400_bib116","first-page":"646","article-title":"[COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2]","volume":"17","author":"Yatim","year":"2021","journal-title":"Rev. Med. Suisse"},{"key":"2025102410025648400_bib117","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1001\/jamadermatol.2020.4324","article-title":"Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic","volume":"157","author":"Hubiche","year":"2021","journal-title":"JAMA Dermatol."},{"key":"2025102410025648400_bib118","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13860","article-title":"Chilblains outbreak during COVID-19 pandemic: A type-I interferonopathy?","volume":"33","author":"Mensa-Vilar\u00f3","year":"2022","journal-title":"Pediatr. Allergy Immunol."},{"key":"2025102410025648400_bib119","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1016\/j.jid.2021.05.024","article-title":"From your nose to your toes: A review of severe acute respiratory syndrome coronavirus 2 pandemic\u2012associated pernio","volume":"141","author":"Arkin","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"2025102410025648400_bib120","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/bjd.20707","article-title":"Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak","volume":"185","author":"Frumholtz","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"2025102410025648400_bib121","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cmi.2021.09.032","article-title":"Chilblains during lockdown are associated with household exposure to SARS-CoV-2: A multicentre case-control study","volume":"28","author":"Poizeau","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"2025102410025648400_bib122","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.annder.2020.11.005","article-title":"Acute acral eruptions in children during the COVID-19 pandemic: Characteristics of 103 children and their family clusters","volume":"148","author":"Hubiche","year":"2021","journal-title":"Ann. Dermatol. Venereol."},{"key":"2025102410025648400_bib123","doi-asserted-by":"publisher","first-page":"110525","DOI":"10.1016\/j.isci.2024.110525","article-title":"Pandemic-associated pernio harbors footprints of an abortive SARS-CoV-2 infection","volume":"27","author":"Arkin","year":"2024","journal-title":"iScience"},{"key":"2025102410025648400_bib124","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231467","article-title":"Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains","volume":"222","author":"Saidoune","year":"2025","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib125","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/bjd.21820","article-title":"COVID-19 pandemic-associated chilblains: More links for SARS-CoV-2 and less evidence for high interferon type I systemic response","volume":"187","author":"Bessis","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"2025102410025648400_bib126","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adm8185","article-title":"Human life within a narrow range: The lethal ups and downs of type I interferons","volume":"9","author":"Crow","year":"2024","journal-title":"Sci. Immunol."},{"key":"2025102410025648400_bib127","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"},{"key":"2025102410025648400_bib128","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1097\/INF.0000000000003274","article-title":"\u201cCOVID toes\u201d in three siblings","volume":"40","author":"Feder","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2025102410025648400_bib129","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.immuni.2024.05.020","article-title":"Human determinants of age-dependent patterns of death from infection","volume":"57","author":"Abel","year":"2024","journal-title":"Immunity"},{"key":"2025102410025648400_bib130","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.pt.2019.06.004","article-title":"The uncertainty surrounding the burden of post-acute consequences of dengue infection","volume":"35","author":"Hung","year":"2019","journal-title":"Trends Parasitol."},{"key":"2025102410025648400_bib131","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa1805435","article-title":"A longitudinal study of Ebola sequelae in Liberia","volume":"380","author":"PREVAIL III Study Group","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib132","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/trstmh\/try063","article-title":"Chikungunya chronic disease: A systematic review and meta-analysis","volume":"112","author":"Paix\u00e3o","year":"2018","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"2025102410025648400_bib133","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1473-3099(15)00134-6","article-title":"Long-term sequelae of West Nile virus-related illness: A systematic review","volume":"15","author":"Patel","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"2025102410025648400_bib134","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1542\/peds.2008-1879","article-title":"Chronic fatigue syndrome after infectious mononucleosis in adolescents","volume":"124","author":"Katz","year":"2009","journal-title":"Pediatrics"},{"key":"2025102410025648400_bib135","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1016\/j.vaccine.2015.10.018","article-title":"Chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine","volume":"33","author":"Magnus","year":"2015","journal-title":"Vaccine"},{"key":"2025102410025648400_bib136","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2377-11-37","article-title":"Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study","volume":"11","author":"Moldofsky","year":"2011","journal-title":"BMC Neurol."},{"key":"2025102410025648400_bib137","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s41591-022-01766-7","article-title":"Studying severe long COVID to understand post-infectious disorders beyond COVID-19","volume":"28","author":"Brodin","year":"2022","journal-title":"Nat. Med."},{"key":"2025102410025648400_bib138","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.cmi.2024.09.001","article-title":"Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study","volume":"30","author":"Swank","year":"2024","journal-title":"Clin. Microbiol. Infect."},{"key":"2025102410025648400_bib139","doi-asserted-by":"publisher","first-page":"100849","DOI":"10.1016\/S2666-5247(24)00055-7","article-title":"Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 condition","volume":"5","author":"Menezes","year":"2024","journal-title":"Lancet Microbe"},{"key":"2025102410025648400_bib140","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.11.24302636","article-title":"Restrained memory CD8+ T cell responses favors viral persistence and elevated IgG responses in patients with severe Long COVID","author":"Rodriguez","year":"2024","journal-title":"medRxiv"},{"key":"2025102410025648400_bib141","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"key":"2025102410025648400_bib142","doi-asserted-by":"publisher","first-page":"iqad003","DOI":"10.1093\/oxfimm\/iqad003","article-title":"Achieving symptom relief in patients with myalgic encephalomyelitis by targeting the neuro-immune interface and optimizing disease tolerance","volume":"4","author":"Rodriguez","year":"2023","journal-title":"Oxf. Open Immunol."},{"key":"2025102410025648400_bib143","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41586-024-07789-z","article-title":"Immune system adaptation during gender-affirming testosterone treatment","volume":"633","author":"Lakshmikanth","year":"2024","journal-title":"Nature"},{"key":"2025102410025648400_bib144","doi-asserted-by":"publisher","DOI":"10.1101\/2024.06.18.24309100","article-title":"A causal link between autoantibodies and neurological symptoms in long COVID","author":"Santos Guedes de Sa","year":"2024","journal-title":"medRxiv"},{"key":"2025102410025648400_bib145","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1016\/j.cell.2023.09.013","article-title":"Serotonin reduction in post-acute sequelae of viral infection","volume":"186","author":"Wong","year":"2023","journal-title":"Cell"},{"key":"2025102410025648400_bib146","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41591-022-01780-9","article-title":"Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults","volume":"28","author":"Killingley","year":"2022","journal-title":"Nat. Med."},{"key":"2025102410025648400_bib147","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41588-022-01042-x","article-title":"Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects","volume":"54","author":"Roberts","year":"2022","journal-title":"Nat. Genet."},{"key":"2025102410025648400_bib148","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41577-021-00631-x","article-title":"The immunology of asymptomatic SARS-CoV-2 infection: What are the key questions?","volume":"21","author":"Boyton","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"2025102410025648400_bib149","doi-asserted-by":"publisher","first-page":"100300","DOI":"10.1016\/j.xhgg.2024.100300","article-title":"Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection","volume":"5","author":"Marchal","year":"2024","journal-title":"HGG Adv."},{"key":"2025102410025648400_bib150","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-023-06331-x","article-title":"A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection","volume":"620","author":"Augusto","year":"2023","journal-title":"Nature"},{"key":"2025102410025648400_bib151","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41586-021-04186-8","article-title":"Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2","volume":"601","author":"Swadling","year":"2022","journal-title":"Nature"},{"key":"2025102410025648400_bib152","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2017.04.025","article-title":"Interferon-\u03bb mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness","volume":"46","author":"Galani","year":"2017","journal-title":"Immunity"},{"key":"2025102410025648400_bib153","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","article-title":"Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison","volume":"22","author":"Galani","year":"2021","journal-title":"Nat. Immunol."},{"key":"2025102410025648400_bib154","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1101\/2020.04.19.20068015","article-title":"Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science."},{"key":"2025102410025648400_bib155","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd6832","article-title":"Natural killer cell immunotypes related to COVID-19 disease severity","volume":"5","author":"Maucourant","year":"2020","journal-title":"Sci. Immunol."},{"key":"2025102410025648400_bib156","doi-asserted-by":"publisher","first-page":"105475","DOI":"10.1016\/j.ebiom.2024.105475","article-title":"An ultra-early, transient interferon-associated innate immune response associates with protection from SARS-CoV-2 infection despite exposure","volume":"111","author":"Fenn","year":"2025","journal-title":"EBioMedicine"},{"key":"2025102410025648400_bib157","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41588-021-01006-7","article-title":"Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease","volume":"54","author":"Horowitz","year":"2022","journal-title":"Nat. Genet."},{"key":"2025102410025648400_bib158","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41590-021-01030-z","article-title":"A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection","volume":"23","author":"Andreakos","year":"2022","journal-title":"Nat. Immunol."},{"key":"2025102410025648400_bib159","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cell.2020.12.006","article-title":"Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks","volume":"184","author":"Schneider","year":"2021","journal-title":"Cell"},{"key":"2025102410025648400_bib160","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib161","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against covid-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib162","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib163","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.xhgg.2021.100084","article-title":"HLA-A*03:01 is associated with increased risk of fever, chills, and stronger side effects from Pfizer-BioNTech COVID-19 vaccination","volume":"3","author":"Bolze","year":"2022","journal-title":"HGG Adv."},{"key":"2025102410025648400_bib164","doi-asserted-by":"publisher","first-page":"101149","DOI":"10.1016\/j.xcrm.2023.101149","article-title":"mRNA vaccination boosts S-specific T cell memory and promotes expansion of CD45RAint TEMRA-like CD8+ T cells in COVID-19 recovered individuals","volume":"4","author":"Mayer-Blackwell","year":"2023","journal-title":"Cell Rep. Med."},{"key":"2025102410025648400_bib165","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14142","article-title":"HLA binding-groove motifs are associated with myocarditis induction after Pfizer-BioNTech BNT162b2 vaccination","volume":"54","author":"Aharon","year":"2024","journal-title":"Eur. J. Clin. Invest."},{"key":"2025102410025648400_bib166","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/cid\/ciab989","article-title":"Epidemiology of acute myocarditis\/pericarditis in Hong Kong adolescents following comirnaty vaccination","volume":"75","author":"Chua","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"2025102410025648400_bib167","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adh3455","article-title":"Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis","volume":"8","author":"Barmada","year":"2023","journal-title":"Sci. Immunol."},{"key":"2025102410025648400_bib168","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s10875-022-01372-9","article-title":"Decoding the human genetic and immunological basis of COVID-19 mRNA vaccine-induced myocarditis","volume":"42","author":"Bolze","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib169","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib170","doi-asserted-by":"publisher","first-page":"24512","DOI":"10.1038\/s41598-024-75514-x","article-title":"Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination","volume":"14","author":"Yalcinkaya","year":"2024","journal-title":"Sci. Rep."},{"key":"2025102410025648400_bib171","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 breakthrough infections in vaccinated health care workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib172","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0140-6736(22)00090-3","article-title":"Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose","volume":"399","author":"Kuhlmann","year":"2022","journal-title":"Lancet"},{"key":"2025102410025648400_bib173","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1001\/jama.2021.19499","article-title":"Association between mRNA vaccination and COVID-19 hospitalization and disease severity","volume":"326","author":"Tenforde","year":"2021","journal-title":"JAMA"},{"key":"2025102410025648400_bib174","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/S2213-2600(21)00413-6","article-title":"Severe breakthrough COVID-19 infections in Scotland-implications for immunisation programmes","volume":"9","author":"Leshem","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"2025102410025648400_bib175","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41577-020-0373-7","article-title":"Severe COVID-19 in the young and healthy: Monogenic inborn errors of immunity?","volume":"20","author":"Zhang","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"2025102410025648400_bib176","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10875-021-01166-5","article-title":"A case of autosomal recessive interferon alpha\/beta receptor alpha chain (IFNAR1) deficiency with severe COVID-19","volume":"42","author":"Khanmohammadi","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib177","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine through 6 Months","volume":"385","author":"Thomas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib178","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abp8966","article-title":"Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs","volume":"8","author":"Bastard","year":"2023","journal-title":"Sci. Immunol."},{"key":"2025102410025648400_bib179","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib180","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early remdesivir to prevent progression to severe covid-19 in outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib181","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10875-021-01023-5","article-title":"Interferon-beta therapy in a patient with incontinentia pigmenti and autoantibodies against type I IFNs infected with SARS-CoV-2","volume":"41","author":"Bastard","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib182","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa2209760","article-title":"Early treatment with pegylated interferon lambda for covid-19","volume":"388","author":"Reis","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"2025102410025648400_bib183","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/289496a0","article-title":"Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon","volume":"289","author":"Vallbracht","year":"1981","journal-title":"Nature"},{"key":"2025102410025648400_bib184","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/s0140-6736(81)91460-4","article-title":"Patient with circulating antibodies to alpha-interferon","volume":"2","author":"Mogensen","year":"1981","journal-title":"Lancet"},{"key":"2025102410025648400_bib185","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/infdis\/150.5.707","article-title":"Characteristics of autoantibodies to human interferon in a patient with varicella-zoster disease","volume":"150","author":"Pozzetto","year":"1984","journal-title":"J. Infect. Dis."},{"key":"2025102410025648400_bib186","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/cells9010072","article-title":"Anti-cytokine autoantibodies in systemic lupus erythematosus","volume":"9","author":"Howe","year":"2019","journal-title":"Cells"},{"key":"2025102410025648400_bib187","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell"},{"key":"2025102410025648400_bib188","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.autrev.2015.01.015","article-title":"Emerging clinical phenotypes associated with anti-cytokine autoantibodies","volume":"14","author":"Vincent","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"2025102410025648400_bib189","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001709","article-title":"Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease","volume":"20","author":"Busnadiego","year":"2022","journal-title":"PLoS Biol."},{"key":"2025102410025648400_bib190","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/imcb.12495","article-title":"Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19","volume":"99","author":"Abers","year":"2021","journal-title":"Immunol. Cell Biol."},{"key":"2025102410025648400_bib191","doi-asserted-by":"publisher","first-page":"102598","DOI":"10.1016\/j.jaut.2021.102598","article-title":"COVID-19 convalescent plasma composition and immunological effects in severe patients","volume":"118","author":"Acosta-Ampudia","year":"2021","journal-title":"J. Autoimmun."},{"key":"2025102410025648400_bib192","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210554","article-title":"Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1","volume":"218","author":"Bastard","year":"2021","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib193","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1038\/s41467-021-25509-3","article-title":"New-onset IgG autoantibodies in hospitalized patients with COVID-19","volume":"12","author":"Chang","year":"2021","journal-title":"Nat. Commun."},{"key":"2025102410025648400_bib194","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1327","article-title":"Antibodies against type I interferon: Detection and association with severe clinical outcome in COVID-19 patients","volume":"10","author":"Goncalves","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"2025102410025648400_bib195","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s00134-021-06392-4","article-title":"Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients","volume":"47","author":"Koning","year":"2021","journal-title":"Intensive Care Med."},{"key":"2025102410025648400_bib196","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s10875-021-01136-x","article-title":"Pre-existing autoantibodies neutralizing high concentrations of type I interferons in almost 10% of COVID-19 patients admitted to intensive care in Barcelona","volume":"41","author":"Solanich","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib197","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s10875-021-01036-0","article-title":"Neutralizing autoantibodies to type I IFNs in &gt;10% of patients with severe COVID-19 pneumonia hospitalized in Madrid, Spain","volume":"41","author":"Troya","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib198","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10875-021-01060-0","article-title":"Neutralizing autoantibodies to type I interferons in COVID-19 convalescent donor plasma","volume":"41","author":"Vazquez","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib199","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"van der Wijst","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"2025102410025648400_bib200","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10875-022-01245-1","article-title":"Diagnosis of APS-1 in two siblings following life-threatening COVID-19 pneumonia","volume":"42","author":"Schidlowski","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib201","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"2025102410025648400_bib202","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1136\/ard-2022-222549","article-title":"Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-\u03b1","volume":"81","author":"Mathian","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"2025102410025648400_bib203","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaci.2021.03.034","article-title":"Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis","volume":"148","author":"Lemarquis","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025102410025648400_bib204","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150867","article-title":"Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1","volume":"131","author":"Meisel","year":"2021","journal-title":"J. Clin. Invest."},{"key":"2025102410025648400_bib205","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.3390\/v13122553","article-title":"Microarray-based detection of antibodies against SARS-CoV-2 proteins, common respiratory viruses and type I interferons","volume":"13","author":"Savvateeva","year":"2021","journal-title":"Viruses"},{"key":"2025102410025648400_bib206","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.cell.2021.07.023","article-title":"Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19","volume":"184","author":"Ziegler","year":"2021","journal-title":"Cell"},{"key":"2025102410025648400_bib207","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abj7521","article-title":"Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort","volume":"14","author":"Carapito","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"2025102410025648400_bib208","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41551-022-00925-y","article-title":"Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries","volume":"6","author":"Credle","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"2025102410025648400_bib209","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s10875-022-01308-3","article-title":"Neutralizing type I interferon autoantibodies in Japanese patients with severe COVID-19","volume":"42","author":"Eto","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib210","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/eji.202249824","article-title":"Anti-IFN-\u03b1\/-\u03c9 neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity","volume":"52","author":"Frasca","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"2025102410025648400_bib211","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s10875-022-01325-2","article-title":"Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization","volume":"42","author":"Lamacchia","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib212","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s10875-021-01168-3","article-title":"Interferon-\u03b12 auto-antibodies in convalescent plasma therapy for COVID-19","volume":"42","author":"Raadsen","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib213","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01280-22","article-title":"Increased presence of antibodies against type I interferons and human endogenous retrovirus W in intensive care unit COVID-19 patients","volume":"10","author":"Simula","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"2025102410025648400_bib214","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12964-022-00903-6","article-title":"A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients","volume":"20","author":"Soltani-Zangbar","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"2025102410025648400_bib215","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10875-022-01252-2","article-title":"Early and rapid identification of COVID-19 patients with neutralizing type I interferon auto-antibodies","volume":"42","author":"Akbil","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib216","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1182\/blood.2021014890","article-title":"Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms","volume":"139","author":"Borsani","year":"2022","journal-title":"Blood"},{"key":"2025102410025648400_bib217","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1056","article-title":"High frequency of type I interferon auto-antibodies in a group of middle-aged HIV-infected patients: A cross-sectional exploratory study","volume":"11","author":"Imberti","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"2025102410025648400_bib218","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10875-023-01512-9","article-title":"Autoantibodies neutralizing type I IFNs in the bronchoalveolar lavage of at least 10% of patients during life-threatening COVID-19 pneumonia","volume":"43","author":"Philippot","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"2025102410025648400_bib219","doi-asserted-by":"publisher","first-page":"17344","DOI":"10.1038\/s41598-023-43675-w","article-title":"Increased blood immune regulatory cells in severe COVID-19 with autoantibodies to type I interferons","volume":"13","author":"Saheb Sharif-Askari","year":"2023","journal-title":"Sci. Rep."},{"key":"2025102410025648400_bib220","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1089\/jir.2023.0087","article-title":"High anti-interferon-alpha autoantibody levels in severe\/critical COVID-19 patients from Peru","volume":"43","author":"Pons","year":"2023","journal-title":"J. Interferon Cytokine Res."},{"key":"2025102410025648400_bib221","doi-asserted-by":"publisher","first-page":"rs.3.rs-915062","DOI":"10.21203\/rs.3.rs-915062\/v1","article-title":"Autoantibodies neutralizing type I interferons in 20% of COVID-19 deaths in a French hospital","author":"Chauvineau-Grenier","year":"2021","journal-title":"Res. Sq."},{"key":"2025102410025648400_bib222","doi-asserted-by":"publisher","first-page":"taad160","DOI":"10.1093\/jtm\/taad160","article-title":"Yellow fever vaccine-associated neurologic and viscerotropic disease: A 10-year case series of the French national reference center for Arboviruses with clinical and immunological insights","volume":"31","author":"Le Hir","year":"2024","journal-title":"J. Trav. Med."},{"key":"2025102410025648400_bib223","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240942","article-title":"Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease","volume":"221","author":"Gervais","year":"2024","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib224","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jaci.2017.11.014","article-title":"Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation","volume":"141","author":"Ramakrishnan","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025102410025648400_bib225","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fped.2019.00061","article-title":"Severe facial herpes vegetans and viremia in NFKB2-deficient common variable immunodeficiency","volume":"7","author":"Parsons","year":"2019","journal-title":"Front. Pediatr."},{"key":"2025102410025648400_bib226","doi-asserted-by":"publisher","first-page":"108851","DOI":"10.1016\/j.clim.2021.108851","article-title":"Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections","volume":"231","author":"Hetem\u00e4ki","year":"2021","journal-title":"Clin. Immunol."},{"key":"2025102410025648400_bib227","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211211","article-title":"Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs","volume":"218","author":"Lopez","year":"2021","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib228","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211387","article-title":"Human autoantibodies underlying infectious diseases","volume":"219","author":"Puel","year":"2022","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib229","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cell.2021.01.050","article-title":"Maturation and persistence of the anti-SARS-CoV-2 memory B cell response","volume":"184","author":"Sokal","year":"2021","journal-title":"Cell"},{"key":"2025102410025648400_bib230","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20242039","article-title":"Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design","volume":"222","author":"Groen","year":"2025","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib231","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1172\/JCI80477","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"125","author":"Walter","year":"2015","journal-title":"J. Clin. Invest."},{"key":"2025102410025648400_bib232","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3389\/fimmu.2018.00544","article-title":"Neutralizing anti-cytokine autoantibodies against interferon-\u03b1 in immunodysregulation polyendocrinopathy enteropathy X-linked","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Front. Immunol."},{"key":"2025102410025648400_bib233","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med."},{"key":"2025102410025648400_bib234","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.immuni.2015.04.021","article-title":"Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases","volume":"42","author":"Oftedal","year":"2015","journal-title":"Immunity"},{"key":"2025102410025648400_bib235","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/pathogens12030403","article-title":"Mild COVID-19 in an APECED patient with chronic inflammatory demyelinating polyneuropathy (CIDP) and high titer of type 1 IFN-abs: A case report","volume":"12","author":"Valenzise","year":"2023","journal-title":"Pathogens"},{"key":"2025102410025648400_bib236","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.clim.2017.09.011","article-title":"Severe Toxoplasma gondii infection in a member of a NFKB2-deficient family with T and B cell dysfunction","volume":"183","author":"Maccari","year":"2017","journal-title":"Clin. Immunol."},{"key":"2025102410025648400_bib237","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41586-023-06717-x","article-title":"Autoantibodies against type I IFNs in humans with alternative NF-\u03baB pathway deficiency","volume":"623","author":"Le Voyer","year":"2023","journal-title":"Nature"},{"key":"2025102410025648400_bib238","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231152","article-title":"Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases","volume":"221","author":"Rosain","year":"2024","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib239","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abe3454","article-title":"Loss-of-function mutation in IKZF2 leads to immunodeficiency with dysregulated germinal center reactions and reduction of MAIT cells","volume":"6","author":"Hetem\u00e4ki","year":"2021","journal-title":"Sci. Immunol."},{"key":"2025102410025648400_bib240","doi-asserted-by":"publisher","DOI":"10.1126\/science.adh4059","article-title":"The immunopathological landscape of human pre-TCR\u03b1 deficiency: From rare to common variants","volume":"383","author":"Materna","year":"2024","journal-title":"Science"},{"key":"2025102410025648400_bib241","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0022-1759(84)90115-7","article-title":"A radioimmunologic technique to screen for antibodies to alpha-2 interferon","volume":"75","author":"Protzman","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"2025102410025648400_bib242","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1440-1746.1989.tb01738.x","article-title":"Detection of anti-interferon-alpha 2a antibodies in chronic liver disease","volume":"4","author":"Ikeda","year":"1989","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2025102410025648400_bib243","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/s0168-8278(94)80018-9","article-title":"Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2 alpha","volume":"20","author":"Bonetti","year":"1994","journal-title":"J. Hepatol."},{"key":"2025102410025648400_bib244","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1128\/cdli.10.1.70-77.2003","article-title":"Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia","volume":"10","author":"Scagnolari","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"2025102410025648400_bib245","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1212\/wnl.47.4.889","article-title":"Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: Experience during the first three years.","volume":"47","author":"IFNB Multiple Sclerosis Study Group and University of British Columbia MS\/MRI Analysis Group","year":"1996","journal-title":"Neurology"},{"key":"2025102410025648400_bib246","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2004.03.013","article-title":"Characterization of the immunoreactivity of anti-interferon alpha antibodies in myasthenia gravis patients. Epitope mapping","volume":"23","author":"Bello-Rivero","year":"2004","journal-title":"J. Autoimmun."},{"key":"2025102410025648400_bib247","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1182\/blood-2010-05-286161","article-title":"Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia","volume":"116","author":"Burbelo","year":"2010","journal-title":"Blood"},{"key":"2025102410025648400_bib248","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.129.1.1","article-title":"Antibodies to alpha-interferon in a patient with systemic lupus erythematosus","volume":"129","author":"Panem","year":"1982","journal-title":"J. Immunol."},{"key":"2025102410025648400_bib249","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/art.39607","article-title":"Distinct functions of autoantibodies against interferon in systemic lupus erythematosus: A comprehensive analysis of anticytokine autoantibodies in common rheumatic diseases","volume":"68","author":"Gupta","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"2025102410025648400_bib250","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451325","article-title":"Highly sensitive reporter cell line for detection of interferon types I-III and their neutralization by antibodies","volume":"54","author":"Groen","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"2025102410025648400_bib251","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2402983121","article-title":"A sensitive assay for measuring whole-blood responses to type I IFNs","volume":"121","author":"Gervais","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025102410025648400_bib252","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114390118","article-title":"Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child","volume":"118","author":"Levy","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025102410025648400_bib253","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1146\/annurev-immunol-101921-050835","article-title":"Interfering with interferons: A critical mechanism for critical COVID-19 pneumonia","volume":"41","author":"Su","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"2025102410025648400_bib254","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01061-20","article-title":"A randomized clinical trial of the efficacy and safety of interferon \u03b2-1a in treatment of severe COVID-19","volume":"64","author":"Davoudi-Monfared","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"2025102410025648400_bib255","article-title":"Early interferon-beta treatment for west-nile virus infection","author":"Tel-Aviv Sourasky Medical Center","year":"2024"},{"key":"2025102410025648400_bib256","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Kariko","year":"2005","journal-title":"Immunity"},{"key":"2025102410025648400_bib257","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"2025102410025648400_bib258","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S2213-2600(24)00179-6","article-title":"Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European region from December, 2020, to March, 2023: A retrospective surveillance study","volume":"12","author":"Mesl\u00e9","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"2025102410025648400_bib259","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275699","article-title":"The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths","volume":"18","author":"Yamana","year":"2023","journal-title":"PLoS One"},{"key":"2025102410025648400_bib260","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.20385","article-title":"Estimated number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US, December 2020 to September 2021","volume":"5","author":"Steele","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"2025102410025648400_bib261","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1377\/hlthaff.2021.00619","article-title":"Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States","volume":"40","author":"Gupta","year":"2021","journal-title":"Health Aff."},{"key":"2025102410025648400_bib262","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1084\/jem.192.2.219","article-title":"Natural interferon alpha\/beta-producing cells link innate and adaptive immunity","volume":"192","author":"Kadowaki","year":"2000","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib263","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220258","article-title":"Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination","volume":"220","author":"Sokal","year":"2023","journal-title":"J. Exp. Med."},{"key":"2025102410025648400_bib264","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.1220098110","article-title":"STAT2 deficiency and susceptibility to viral illness in humans","volume":"110","author":"Hambleton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025102410025648400_bib265","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4049\/jimmunol.2001451","article-title":"Genetic, immunological, and clinical features of 32 patients with autosomal recessive STAT1 deficiency","volume":"207","author":"Le Voyer","year":"2021","journal-title":"J. Immunol."},{"key":"2025102410025648400_bib266","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250003","article-title":"Human inborn effors of immunity: 2024 update on the classification from the international union of immunological societies expert committee","volume":"1","author":"Poli","year":"2025","journal-title":"J. Hum. Immun."},{"key":"2025102410025648400_bib267","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250002","article-title":"The 2024 update of IUIS phenotypic classification of human inborn errors of immunity","volume":"1","author":"Bousfiha","year":"2025","journal-title":"J. Hum. Immun."}],"container-title":["Journal of Human Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jhi\/article-pdf\/doi\/10.70962\/jhi.20250149\/1952095\/jhi_20250149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jhi\/article-pdf\/doi\/10.70962\/jhi.20250149\/1952095\/jhi_20250149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:03:06Z","timestamp":1761314586000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jhi\/article\/1\/4\/e20250149\/278396\/The-seven-enigmas-of-SARS-CoV-2-From-the-past-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":267,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.70962\/jhi.20250149","relation":{},"ISSN":["3065-8993"],"issn-type":[{"value":"3065-8993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"article-number":"e20250149"}}